[Pneumococcal meningitis and resistant bacteria]

D Floret1

  • 1Service d'urgence et réanimation pédiatriques, hôpital Edouard-Herriot, place d'Arsonval 69437 Lyon, Lyon, France. daniel.floret@chu-lyon.fr

Insights

Bacterial meningitis treatment protocols are changing due to Streptococcus pneumoniae resistance. A combination of C3G and vancomycin is now recommended for S. pneumoniae meningitis, with treatment adjusted based on bacterial susceptibility.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Context:

  • Emerging antibiotic resistance in Streptococcus pneumoniae necessitates updated treatment guidelines for bacterial meningitis.
  • Traditional therapies like amoxicillin are becoming less effective.
  • The appearance of resistance to third-generation cephalosporins (C3G) requires alternative therapeutic strategies.

Purpose:

  • To review and recommend updated treatment protocols for Streptococcus pneumoniae meningitis in light of increasing antimicrobial resistance.
  • To evaluate the efficacy of combination therapies and alternative agents.
  • To highlight essential monitoring and diagnostic measures.

Summary:

  • Amoxicillin is no longer a suitable primary treatment for S. pneumoniae meningitis.
  • A combination of C3G and vancomycin demonstrates synergistic effects and is recommended for suspected S. pneumoniae meningitis.
  • Treatment adjustments are based on bacterial minimum inhibitory concentration (MIC) and clinical response. Alternative options include rifampicin, fosfomycin, or imipenem.
  • Monitoring includes oxacillin disk testing for penicillin resistance, C3G MIC measurement, and cerebrospinal fluid (CSF) sterilization checks.

Impact:

  • The recommended C3G and vancomycin combination aims to improve therapeutic outcomes in resistant meningitis cases.
  • Careful patient monitoring and susceptibility testing are crucial for successful treatment and preventing therapeutic failure.
  • The development of new vaccines and quinolones may further alter the management landscape of resistant pneumococcal meningitis.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...